InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-27)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Sector1,598

Healthcare & Pharma

Five Star Senior Living INC.

Flexion Therapeutics Inc

Foghorn Therapeutics Inc.

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forma Therapeutics Holdings, Inc.

Forte Biosciences, Inc.

Forza Innovations Inc

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

Fresenius SE & Co. KGaA

Fulcrum Therapeutics, Inc.

Fulgent Genetics, Inc.

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

GMR Solutions Inc.

GT Biopharma, Inc.

GW Pharmaceuticals PLC

Gain Therapeutics, Inc.

Galderma Group AG

Galectin Therapeutics INC

Galera Therapeutics, Inc.

Gamida Cell Ltd.

Gelesis Holdings, INC.

Gemini Therapeutics, Inc. /DE

Gemini Therapeutics, Inc. /DE

GeneDx Holdings Corp.

Generation Bio Co.

Genesis Healthcare, Inc.

Genufood Energy Enzymes Corp.

Gerresheimer AG

← PreviousPage 13 of 32Next →